Literature DB >> 2824739

Effects of berberine on basal and secretagogue-modified ion transport in the rabbit ileum in vitro.

S Guandalini1, A Fasano, M Migliavacca, G Marchesano, A Ferola, A Rubino.   

Abstract

The antisecretory effect of berberine sulfate (BS) was determined in the rabbit ileal mucosa in vitro mounted in Ussing chambers. When present in the luminal side, the drug had no effect on potential difference (PD) or on the short-circuit current (Isc) changes induced by theophylline or prostaglandin E2 (PGE2). When present in the serosal medium at a concentration of 2 mM, however, berberine reduced PD and Isc and abolished residual ion flux (bicarbonate secretion) but had no significant affect on basal net Na and Cl transepithelial transport. BS effect on basal PD was not affected by the absence of Ca2+ in the medium; neither was it inhibited by the alpha-adrenergic blocker yohimbine. Serosally added BS effectively antagonized the secretory effect on Isc of agents that increase each of the known intracellular mediators of ion secretion: cyclic 3',5'-adenosine monophosphate (cAMP), cyclic 3',5'-guanosine monophosphate (cGMP), and Ca2+; it also inhibited the ion transport modifications evoked by PGE2. The drug had no effect on the concentration of cyclic nucleotides either under basal condition or in the presence of some secretagogues. Finally, BS did not impair the PD rise due to luminal addition of glucose.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824739     DOI: 10.1097/00005176-198711000-00023

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  10 in total

1.  Enterotoxin and cytotoxin production by enteroinvasive Escherichia coli.

Authors:  A Fasano; B A Kay; R G Russell; D R Maneval; M M Levin
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Involvement of the enteroaggregative Escherichia coli plasmid-encoded toxin in causing human intestinal damage.

Authors:  I R Henderson; S Hicks; F Navarro-Garcia; W P Elias; A D Philips; J P Nataro
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

3.  espC pathogenicity island of enteropathogenic Escherichia coli encodes an enterotoxin.

Authors:  J L Mellies; F Navarro-Garcia; I Okeke; J Frederickson; J P Nataro; J B Kaper
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

4.  Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro.

Authors:  A Fasano; F R Noriega; D R Maneval; S Chanasongcram; R Russell; S Guandalini; M M Levine
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

5.  Role of Vibrio cholerae neuraminidase in the function of cholera toxin.

Authors:  J E Galen; J M Ketley; A Fasano; S H Richardson; S S Wasserman; J B Kaper
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

6.  Berberine inhibition of electrogenic ion transport in rat colon.

Authors:  C T Taylor; A W Baird
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

7.  Enterotoxigenicity of Vibrio parahaemolyticus with and without genes encoding thermostable direct hemolysin.

Authors:  M Nishibuchi; A Fasano; R G Russell; J B Kaper
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

8.  Berberine Reduces cAMP-Induced Chloride Secretion in T84 Human Colonic Carcinoma Cells through Inhibition of Basolateral KCNQ1 Channels.

Authors:  Rodrigo Alzamora; Fiona O'Mahony; Wing-Hung Ko; Tiffany Wai-Nga Yip; Derek Carter; Mustapha Irnaten; Brian Joseph Harvey
Journal:  Front Physiol       Date:  2011-06-30       Impact factor: 4.566

9.  In vitro effects of a high-molecular-weight heat-labile enterotoxin from enteroaggregative Escherichia coli.

Authors:  F Navarro-García; C Eslava; J M Villaseca; R López-Revilla; J R Czeczulin; S Srinivas; J P Nataro; A Cravioto
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

10.  Pet, an autotransporter enterotoxin from enteroaggregative Escherichia coli.

Authors:  C Eslava; F Navarro-García; J R Czeczulin; I R Henderson; A Cravioto; J P Nataro
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.